We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$489B
$143M 12.13%
400,000
+50,000
+14% +$18.5M
GSK icon
2
GSK
GSK
$102B
$118M 10%
3,259,342
+378,330
+13% +$13.4M
NTRA icon
3
Natera
NTRA
$47B
$110M 9.33%
2,492,636
+78,849
+3% +$4.02M
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$103M 8.68%
240,000
+10,000
+4% +$4.45M
TEVA icon
5
Teva Pharmaceuticals
TEVA
$42.5B
$70.9M 6%
6,952,085
-715,959
-9% -$6.67M
UTHR icon
6
United Therapeutics
UTHR
$22.1B
$60.5M 5.12%
267,903
+7,505
+3% +$1.73M
INSP icon
7
Inspire Medical Systems
INSP
$1.78B
$38.3M 3.24%
193,018
+110,573
+134% +$27.9M
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.74B
$37.7M 3.19%
2,596,245
+406,513
+19% +$7.69M
HCA icon
9
HCA Healthcare
HCA
$90.5B
$27.1M 2.29%
110,073
+29,348
+36% +$8.03M
TECH icon
10
Bio-Techne
TECH
$11.3B
$26.3M 2.22%
385,889
+43,252
+13% +$3.42M
DHR icon
11
Danaher
DHR
$152B
$25.7M 2.18%
117,068
+495
+0.4% +$110K
HQY icon
12
HealthEquity
HQY
$7.97B
$24.7M 2.09%
+338,516
New +$22.9M
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$23.8M 2.01%
205,815
-269,495
-57% -$29M
ILMN icon
14
Illumina
ILMN
$32.6B
$22.9M 1.94%
171,452
+43,927
+34% +$7.22M
CYH icon
15
Community Health Systems
CYH
$413M
$20.7M 1.75%
7,146,088
-131,768
-2% -$488K
VERA icon
16
Vera Therapeutics
VERA
$2.46B
$20.3M 1.72%
1,478,489
-262,462
-15% -$4.5M
BCRX icon
17
BioCryst Pharmaceuticals
BCRX
$2.51B
$17.6M 1.49%
2,479,103
+106,990
+5% +$769K
SWAV
18
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$16.8M 1.42%
84,462
+64,324
+319% +$15.2M
CLDX icon
19
Celldex Therapeutics
CLDX
$3.07B
$16.2M 1.37%
588,143
-197,597
-25% -$6.19M
CNC icon
20
Centene
CNC
$32B
$13.1M 1.11%
190,607
+37,874
+25% +$2.52M
KRYS icon
21
Krystal Biotech
KRYS
$10.4B
$12.6M 1.07%
108,771
+2,306
+2% +$281K
IONS icon
22
Ionis Pharmaceuticals
IONS
$10.1B
$11.5M 0.97%
252,446
+10,874
+5% +$449K
AMRX icon
23
Amneal Pharmaceuticals
AMRX
$6.11B
$11.2M 0.94%
2,644,988
-2,620,263
-50% -$9.77M
PCVX icon
24
Vaxcyte
PCVX
$8.9B
$9.71M 0.82%
190,430
-5,261
-3% -$260K
TARO
25
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$9.63M 0.81%
255,323
+5,037
+2% +$189K
1
2 3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.